BACKGROUND: The aim of our study was to assess the prevalence of anxiety and depression
in the whole chronic obstructive pulmonary disease (COPD) population and in subgroups …

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and the related coronavirus
disease 2019 (COVID-19) hit Europe in February 2020 [1], raising issues on acute phase …

Indacaterol is a novel, inhaled, once-daily, ultra-long-acting β 2 -agonist bronchodilator
recently approved in Europe for the treatment of chronic obstructive pulmonary disease (COPD). …

Background In hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia,
progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is …

BACKGROUND: We investigated the correlation between patients’ characteristics, including
anxiety and depression, and the level of asthma control evaluated by asthma control test (…

Background COVID-19 is an infectious disease caused by a novel coronavirus (SARS-CoV-2).
The immunopathogenesis of the infection is currently unknown. Healthcare workers (…

This document is protected by international copyright laws. No additional reproduction is
authorized. It is permitted for personal use to download and save only one file and print only …

Background and purpose Cognitive dysfunction has been observed following recovery from
COVID‐19. To the best of our knowledge, however, no study has assessed the progression …

Even though it is generally accepted that anxiety and depression are more common in
asthmatic patients and that there is a close correlation between psychological disorders and …

Background Environmental pollution is a known risk factor for multiple diseases and furthermore
increases rate of hospitalisations. We investigated the correlation between emergency …